••Shetty M, Chowdhury YS. Heart Transplantation Allograft Vasculopathy. [Updated 2023 May 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555999/ This article was very formative in this review, because it contains the most current, peer-reviewed epidemiological statistics on CAV. Largely, the importance of our review is derived from the vast mortality of CAV, which was quantified based on the contents of this article.

Ramzy D, Rao V, Brahm J, Miriuka S, Delgado D, Ross HJ. Cardiac allograft vasculopathy: a review. Can J Surg. 2005;48(4):319–27.

PubMed  PubMed Central  Google Scholar 

Anyanwu A, Treasure T. Prognosis after heart transplantation: transplants alone cannot be the solution for end stage heart failure. BMJ. 2003;326(7388):509–10. https://doi.org/10.1136/bmj.326.7388.509.

Article  PubMed  PubMed Central  Google Scholar 

••Pober JS, Chih S, Kobashigawa J, Madsen JC, Tellides G. Cardiac allograft vasculopathy: current review and future research directions. Cardiovasc Res. 2021 Nov 22;117(13):2624-2638. doi: https://doi.org/10.1093/cvr/cvab259. This article was very significant in this review because it outlined the increasing mortality of heart transplant recipients due to CAV as time PT increased. The foundation for the claims on the potential for CAV to be the limiting factor in extending the average life expectancy for heart transplant recipients is derived partially from this article.

Chih S, Chong AY, Mielniczuk LM, Bhatt DL, Beanlands RS. Allograft vasculopathy: the Achilles’ heel of heart transplantation. J Am Coll Cardiol. 2016;68(1):80–91. https://doi.org/10.1016/j.jacc.2016.04.033.

Article  PubMed  Google Scholar 

Cassar A, Holmes DR Jr, Rihal CS, Gersh BJ. Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 2009;84(12):1130–46. https://doi.org/10.4065/mcp.2009.0391.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Segura AM, Buja LM. Cardiac allograft vasculopathy: a complex multifactorial sequela of heart transplantation. Tex Heart Inst J. 2013;40(4):400–2.

PubMed  PubMed Central  Google Scholar 

Pighi M, Gratta A, Marin F, Bellamoli M, Lunardi M, Fezzi S, Zivelonghi C, Pesarini G, Tomai F, Ribichini F. Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy. Transplant Rev (Orlando). 2020;34(4): 100569. https://doi.org/10.1016/j.trre.2020.100569.

Article  PubMed  Google Scholar 

Skorić B, Čikeš M, Ljubas Maček J, Baričević Ž, Škorak I, Gašparović H, Biočina B, Miličić D. Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis. Croat Med J. 2014;55(6):562–76. https://doi.org/10.3325/cmj.2014.55.562.

Article  CAS  PubMed  PubMed Central  Google Scholar 

US Department of Health and Human Services. (n.d.). OPTN/SRTR 2019 Annual data report: Heart - health resources and ... Scientific Registry of Transplant Recipients. https://srtr.transplant.hrsa.gov/annual_reports/2019/Heart.aspx

•• Suarez-Pierre A, Lui C, Zhou X, Giuliano K, Etchill E, Almaraz-Espinoza A, Crawford TC, Fraser CD 3rd, Whitman GJ, Choi CW, Higgins RS, Kilic A. Long-term Survival After Heart Transplantation: A Population-based Nested Case-Control Study. Ann Thorac Surg. 2021 Mar;111(3):889-898. https://doi.org/10.1016/j.athoracsur.2020.05.163. This article is significant to this review, because it is a large-scale, peer-review case control study analyzing more than 30,000 heart transplant recipients. Thorough demographic data was collected including cause of death.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—A web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https://doi.org/10.1186/s13643-016-0384-4.

Article  PubMed  PubMed Central  Google Scholar 

Review Manager Web (RevMan Desktop). Version 5.4.1. The Cochrane Collaboration, (2023). https://login.cochrane.org/

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol. 2007;50(20):1967–72. https://doi.org/10.1016/j.jacc.2007.07.068.

Article  PubMed  Google Scholar 

Densem CG, Wassel J, Cooper A, Yonan N, Brooks NH, Keevil B. Haptoglobin phenotype correlates with development of cardiac transplant vasculopathy. J Heart Lung Transplant. 2004;23(1):43–9. https://doi.org/10.1016/S1053-2498(03)00061-5.

Article  PubMed  Google Scholar 

Javaheri A, Molina M, Zamani P, Rodrigues A, Novak E, Chambers S, Stutman P, Maslanek W, Williams M, Lilly SM, Heeger P, Sayegh MH, Chandraker A, Briscoe DM, Daly KP, Starling R, Ikle D, Christie J, Eduardo Rame J, Goldberg LR, Billheimer J, Rader DJ. Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2016;35(11):1295–302. https://doi.org/10.1016/j.healun.2016.06.022.

Article  PubMed  PubMed Central  Google Scholar 

• Kondziella, C., Fluschnik, N., Weimann, J., Bernhard, A. M., Schrage, B., Blankenberg, S., Reichenspurner, H., Kirchhof, P., Schnabel, R. B., & Magnussen, C. (2022). Sex Differences in Clinical Characteristics and Outcomes in Patients Undergoing Heart Transplantation. Journal of Heart and Lung Transplantation, 41(4), S152. https://doi.org/10.1016/j.healun.2022.01.361. This study significantly contributed to this review by performing multivariable analysis of sex differences in outcomes of heart transplant patients via a prospective cohort study of more than 49,000 patients. Their study found that male gender was a risk factor CAV, but when this finding was subjected to meta-analysis, it failed to meet significance in our study.

Lazarte J, Goldraich L, Manlhiot C, Billia F, Ross H, Rao V, Delgado D. Human leukocyte antigen G single-nucleotide polymorphism-201 (CC–CC) donor–recipient genotype matching as a predictor of severe cardiac allograft vasculopathy. J Heart Lung Transplant. 2016;35(9):1101–7. https://doi.org/10.1016/j.healun.2016.04.014.

Article  PubMed  Google Scholar 

Van Keer JM, Van Aelst LNL, Rega F, Droogne W, Voros G, Meyns B, Vanhaecke J, Emonds MP, Janssens S, Naesens M, Van Cleemput J. Long-term outcome of cardiac allograft vasculopathy: importance of the International Society for Heart and Lung Transplantation angiographic grading scale. J Heart Lung Transplant. 2019;38(11):1189–96. https://doi.org/10.1016/j.healun.2019.08.005.

Article  PubMed  Google Scholar 

Evan P. Kransdorf, Jon A. Kobashigawa, 44 - Heart Transplantation, Editor(s): G. Michael Felker, Douglas L. Mann, In Companion to Braunwald’s Heart Disease, Heart Failure: a Companion to Braunwald’s Heart Disease (Fourth Edition), Elsevier, 2020, Pages 631–648.e4, https://doi.org/10.1016/B978-0-323-60987-6.00044-2.